Plasma Vitronectin Predicts Response to Fluoropyrimidine-oxaliplatin (FOLFOX) Chemotherapy in Metastatic Colorectal Cancer

Video   Jul 21, 2015

 

Current assessment is based on computed tomography scans, approximately 6-8 weeks after treatment. Earlier molecular predictors of response would be highly beneficial for both patients and clinicians. We have investigated whether useful protein biomarkers could be found in patient plasma, through the use of an advanced MS technique known as SRM-MS. Here, we will discuss the discovery-through-validation pipeline of identifying and validating clinically-relevant biomarkers that can be rapidly translated into the clinic. Briefly, we examined whether the type of blood collection tube would impact on SRM measurement of plasma proteins, in addition to examining the stability of the selected plasma proteome over a 19 week time-course. We then applied SRM to monitor 31 plasma proteins in a trial cohort of advanced CRC patients receiving FOLFOX chemotherapy. Our results indicated that the baseline levels of plasma vitronectin were associated with chemotherapy response, which was successfully validated in a larger patient cohort using SRM and ELISA (n=29 patients). These findings pave the way for further testing in larger cohorts and could lead to more cost-effective and rational uses of systemic chemotherapy.

 
 
 
 

Recommended Videos

IMMUNOTHERAPY: The Path to a Cancer Cure

Video

IMMUNOTHERAPY: The Path to a Cancer Cure (For Patients) explains the interplay between the immune system and cancer; mechanisms underlying immune-based agents; and different approaches to cancer immunotherapeutics.

WATCH NOW

Behind the Science, S3 Ep 1: Exploring new dimensions in chromatography with Claude Mallet

Video

To kick off season 3 of Behind the Science, our host Jen Fournier meets Claude Mallet of Waters at his new multi-dimensional chromatography lab to break down the myths of 2D LC, also known as LCxLC.

WATCH NOW

The Role of Proteogenomics in Cancer Research

Video

Proteomics is the comprehensive study of the complete set of proteins in an organism (called the proteome). Analyzing the proteome of a patient’s cancer can also provide information on how to best diagnose and treat the patient.

WATCH NOW

 

Comments | 0 ADD COMMENT

Like what you just watched? You can find similar content on the communities below.

Analysis & Separations Cancer Research Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy